E L Tierney
Overview
Explore the profile of E L Tierney including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
915
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stokes A, Tierney E, Sarris C, Murphy B, Hall S
Virus Res
. 1993 Oct;
30(1):43-52.
PMID: 8266719
Two cold-passaged mutant vaccine viruses (cp12 and cp45) derived from the JS wild-type (wt) strain of human parainfluenza virus type 3 (PIV3) have been sequenced. These mutant viruses display the...
2.
Hall S, Sarris C, Tierney E, London W, Murphy B
J Infect Dis
. 1993 Apr;
167(4):958-62.
PMID: 8383726
A live attenuated cold-adapted parainfluenza virus type 3 (PIV-3) vaccine is being developed to prevent the serious lower respiratory tract disease caused by this virus in infants and young children....
3.
Stokes A, Tierney E, Murphy B, Hall S
Virus Res
. 1992 Sep;
25(1-2):91-103.
PMID: 1329377
The nucleotide sequence of the JS strain of human parainfluenza virus type 3 (PIV3) was determined from a series of 14 overlapping cDNA clones and was compared to that of...
4.
Belshe R, Karron R, Newman F, Anderson E, Nugent S, Steinhoff M, et al.
J Clin Microbiol
. 1992 Aug;
30(8):2064-70.
PMID: 1323576
Cold passage 18 (CP18) parainfluenza virus type 3 (PIV-3) vaccine was evaluated in a double-blind, randomized, placebo-controlled study of 95 infants and young children. None of 19 seropositive older children...
5.
Hall S, Stokes A, Tierney E, London W, Belshe R, Newman F, et al.
Virus Res
. 1992 Mar;
22(3):173-84.
PMID: 1320790
Cold-passaged (CP) mutants derived from the JS strain of wild type wt parainfluenza type 3 virus (PIV3) are being evaluated as candidate live virus vaccines. The wt virus was serially...
6.
Treanor J, Tierney E, London W, Murphy B
Vaccine
. 1991 Jul;
9(7):495-501.
PMID: 1897305
A unique requirement for live attenuated reassortant influenza vaccines is the need to generate new reassortant vaccine viruses with the appearance of each new antigenic variant. Thus, the attenuation phenotype...
7.
Clements M, Belshe R, King J, Newman F, Westblom T, Tierney E, et al.
J Clin Microbiol
. 1991 Jun;
29(6):1175-82.
PMID: 1650789
In an attempt to evaluate the level of attenuation of live parainfluenza type 3 virus (PIV3) vaccine candidates, we compared the responses of partially immune adult volunteers inoculated intranasally with...
8.
van Wyke Coelingh K, WINTER C, Tierney E, Hall S, London W, Kim H, et al.
J Virol
. 1990 Aug;
64(8):3833-43.
PMID: 1695256
An unusual feature of human parainfluenza virus type 3 (PIV3) is ita ability to cause reinfection with high efficiency. The antibody responses of 45 humans and 9 rhesus monkeys to...
9.
Treanor J, Tierney E, Zebedee S, Lamb R, Murphy B
J Virol
. 1990 Mar;
64(3):1375-7.
PMID: 2304147
The M2 protein of influenza A virus is expressed on the surfaces of infected cells, and a monoclonal antibody to this protein inhibits plaque enlargement of sensitive influenza A viruses...
10.
Coelingh K, Tierney E
J Virol
. 1989 Sep;
63(9):3755-60.
PMID: 2474672
Neutralizing monoclonal antibodies specific for the fusion (F) glycoprotein of human parainfluenza type 3 virus (PIV3) were used to select neutralization-resistant antigenic variants. Sequence analysis of the F genes of...